Cibus, Inc. (NASDAQ:CBUS – Get Free Report) CFO Carlo Broos sold 4,647 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $5.30, for a total transaction of $24,629.10. Following the transaction, the chief financial officer now owns 74,197 shares of the company’s stock, valued at approximately $393,244.10. This represents a 5.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Cibus Trading Down 2.4 %
Shares of CBUS stock opened at $4.78 on Friday. The stock has a 50 day simple moving average of $4.03 and a 200 day simple moving average of $8.58. Cibus, Inc. has a 1 year low of $2.86 and a 1 year high of $23.18.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on CBUS shares. HC Wainwright reissued a “buy” rating and issued a $25.00 price objective on shares of Cibus in a report on Monday. Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a report on Friday, July 19th. Alliance Global Partners cut their price objective on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of CBUS. Old West Investment Management LLC lifted its position in shares of Cibus by 3.6% during the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock worth $524,000 after buying an additional 1,868 shares during the last quarter. FineMark National Bank & Trust raised its stake in Cibus by 24.3% during the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after acquiring an additional 4,000 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Cibus by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock worth $161,000 after acquiring an additional 6,276 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Cibus during the 3rd quarter valued at approximately $33,000. Finally, Squarepoint Ops LLC acquired a new position in Cibus during the 2nd quarter worth approximately $214,000. Institutional investors and hedge funds own 33.81% of the company’s stock.
About Cibus
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Articles
- Five stocks we like better than Cibus
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Top-Performing Non-Leveraged ETFs This Year
- How to Most Effectively Use the MarketBeat Earnings Screener
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.